Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico

Journal of Digestive Diseases

Volumn 14, Issue 9, 2013, Pages 491-499

  Purcell, Maura ^a   Flores, Yvonne N ^a,b   Zhang, Zuo Feng ^a   Denova Gutiérrez, Edgar ^b,d   Salmeron, Jorge ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

Author keywords

Adolescent; Liver disease; Metabolic syndrome; Mexico; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY FAT; BODY WEIGHT; CHILD; CHILDHOOD OBESITY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MEXICO; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; URBAN POPULATION;

ADOLESCENT; LIVER DISEASE; METABOLIC SYNDROME; MEXICO; OBESITY;

ADOLESCENT; ALANINE TRANSAMINASE; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY WEIGHT; CHILD; CLINICAL ENZYME TESTS; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MEXICO; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84881650142     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12072     Document Type: Article

References (62)

1. Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004; 8: 549-558.
2. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115: e561-565.
3. Quirós-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI ≥95th percentile. J Pediatr Gastroenterol Nutr 2007; 44: 228-236.
4. Sathya P, Martin S, Alvarez F. Nonalcoholic fatty liver disease (NAFLD) in children. Curr Opin Pediatr 2002; 14: 593-600.
5. Patton HM, Yates K, Unalp-Arida A etal. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010; 105: 2093-2102.
6. Denzer C, Thiere D, Muche R etal. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 2009; 94: 3872-3881.
7. Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr 2009; 49: 442-449.
8. Flores-Calderón J, Gómez-Díaz RA, Rodríguez-Gómez G, Morán-Villota S. Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City. Ann Hepatol 2005; 4: 279-283.
9. Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 2006; 130: 2023-2030.
10. Janssen I, Katzmarzyk PT, Srinivasan SR etal. Combined influence of body mass index and waist circumference on coronary artery disease risk factors among children and adolescents. Pediatrics 2005; 115: 1623-1630.
11. Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. J Zhejiang Univ Sci B 2008; 9: 616-622.
12. Oh SY, Cho YK, Kang MS etal. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006; 55: 1604-1609.
13. Sharp DB, Santos LA, Cruz ML. Fatty liver in adolescents on the U.S.-Mexico border. J Am Acad Nurse Pract 2009; 21: 225-230.
14. Shaibi GQ, Goran MI. Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance. J Pediatr 2008; 152: 171-176.
15. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007; 115: 2316-2322.
16. Goodman E. Metabolic syndrome and the mismeasure of risk. J Adolesc Health 2008; 42: 538-540.
17. Bethel MA, Deedwania P, Levitt NS etal.; NAVIGATOR Study Group. Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. Diabet Med 2009; 26: 1204-1211.
18. Ford ES, Mokdad AH. Epidemiology of obesity in the western hemisphere. J Clin Endocrinol Metab 2008; 93: S1-8.
19. Schwimmer JB, Behling C, Newbury R etal. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005; 42: 641-649.
20. Sistema Nacional de Información en Salud. Principales causas de mortalidad general. 2008. [Available from URL: http://www.sinais.salud.gob.mx]. Mexico City, Mexico. [Updated 1 July 2011; Cited Oct 2011]. Available from URL: http://www.sinais.salud.gob.mx/mortalidad/index.html (In Spanish).
21. Sistema Nacional de Información en Salud. Principales causas de mortalidad en edad productiva (de 15 a 64 años), 2008. [Available from URL: http://www.sinais.salud.gob.mx]. Cited: Oct 2011. Available from URL: http://www.sinais.salud.gob.mx/mortalidad/index.html (In Spanish).
22. Halley Castillo E, Borges G, Talavera JO etal. Body mass index and the prevalence of metabolic syndrome among children and adolescents in two Mexican populations. J Adolesc Health 2007; 40: 521-526.
23. Denova-Gutiérrez E, Jiménez-Aguilar A, Halley-Castillo E etal. Association between sweetened beverage consumption and body mass index, proportion of body fat and body fat distribution in Mexican adolescents. Ann Nutr Metab 2008; 53: 245-251.
24. Katon JG, Flores YN, Salmerón J. Sexual maturation and metabolic profile among adolescents and children of the Health Worker Cohort Study in Mexico. Salud Publica Mex 2009; 51: 219-226.
25. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
26. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-1732.
27. Zimmet P, Alberti KG, Kaufman F etal; IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007; 8: 299-306.
28. Taylor RW, Jones IE, Williams SM, Goulding A. Body fat percentages measured by dual-energy X-ray absorptiometry corresponding to recently recommended body mass index cutoffs for overweight and obesity in children and adolescents aged 3-18 y. Am J Clin Nutr 2002; 76: 1416-1421.
29. Pickering TG, Hall JE, Appel LJ etal; Council on High Blood Pressure Research Professional and Public Education Subcommittee, American Heart Association. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 2005; 7: 102-109.
30. Chowdhury P, Balluz L, Town M etal.; Centers for Disease Control and Prevention (CDC). Surveillance of certain health behaviors and conditions among states and selected local areas - Behavioral Risk Factor Surveillance System, United States, 2007. MMWR Surveill Summ 2010; 59: 1-220.
31. Bergmeyer HU, Hørder M, Rej R. International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem 1986; 24: 481-495.
32. Gella FJ, Olivella T, Cruz Pastor M etal. A simple procedure for the routine determination of aspartate aminotransferase and alanine aminotransferase with pyridoxal phosphate. Clin Chim Acta 1985; 153: 241-247.
33. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 2007; 133: 1814-1820.
34. Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 2005; 41: 426-429.
35. Romero-Polvo A, Denova-Gutiérrez E, Rivera-Paredez B etal. Association between dietary patterns and insulin resistance in Mexican children and adolescents. Ann Nutr Metab 2012; 61: 142-150.
36. Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res Clin Pract 2008; 81: 321-326.
37. Goessling W, Massaro JM, Vasan RS, D'Agostino RB Sr, Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008; 135: 1935-1944.
38. Carrillo-Iregui A, Lopez-Mitnik G, Cossio S, Garibay-Nieto N, Arheart KL, Messiah SE. Relationship between aminotransferases levels and components of the metabolic syndrome among multiethnic adolescents. J Pediatr Endocrinol Metab 2010; 23: 1253-1261.
39. Kelishadi R, Cook SR, Adibi A etal. Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents. Diabetol Metab Syndr 2009; 1: 29.
40. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005; 82: 1046-1051.
41. van Vliet M, von Rosenstiel IA, Schindhelm RK, Brandjes DP, Beijnen JH, Diamant M. The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin. Eur J Pediatr 2009; 168: 585-591.
42. Burgert TS, Taksali SE, Dziura J etal. Alanine amino-transferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006; 91: 4287-4294.
43. Yamamoto-Kimura L, Posadas-Romero C, Posadas-Sánchez R, Zamora-González J, Cardoso-Saldaña G, Méndez Ramírez I. Prevalence and interrelations of cardiovascular risk factors in urban and rural Mexican adolescents. J Adolesc Health 2006; 38: 591-598.
44. Salazar-Martinez E, Allen B, Fernandez-Ortega C, Torres-Mejia G, Galal O, Lazcano-Ponce E. Overweight and obesity status among adolescents from Mexico and Egypt. Arch Med Res 2006; 37: 535-542.
45. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinico-pathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003; 143: 500-505.
46. Mattar SG, Velcu LM, Rabinovitz M etal. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 2005; 242: 610-620.
47. Kotronen A, Peltonen M, Hakkarainen A etal. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009; 137: 865-872.
48. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-827.
49. Weiss R, Dziura J, Burgert TS etal. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
50. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 108-113.
51. Ford ES, Ajani UA, Mokdad AH; National Health and Nutrition Examination. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 2005; 28: 878-881.
52. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004; 110: 2494-2497.
53. Schwimmer JB, Celedon MA, Lavine JE etal. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009; 136: 1585-1592.
54. Instituto Mexicano de Estadística y Geografía. Conteo de población y vivienda 2005. 2005. [Update 2011; Cited September 2011]. Available from URL: http://www.inegi.org.mx/est/contenidos/proyectos/ccpv/cpv2005/Default.aspx (In Spanish).
55. Flores YN, Yee HF Jr, Leng M etal. Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol 2008; 103: 2231-2238.
56. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006; 101: 76-82.
57. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010; 52: 1156-1161.
58. Chen CH, Nien CK, Yang CC, Yeh YH. Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci 2010; 55: 1752-1760.
59. Lonardo A, Loria P. NAFLD and cardiovascular risk: direct evidence for the tale of two ages. Am J Gastroenterol 2009; 104: 1851-1852.
60. Lizardi-Cervera J, Aguilar-Zapata D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol 2009; 8 Suppl 1: S40-43.
61. Arase Y, Suzuki F, Ikeda K, Kumada H, Tsuji H, Kobayashi T. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. J Gastroenterol 2009; 44: 1064-1070.
62. Stevens G, Dias RH, Thomas KJ etal. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med 2008; 5: e125.